Reach Us +44-1235425476
Interview | Aruna TurakanbspJournal of Nuclear Medicine
ISSN: 2155-9619

Journal of Nuclear Medicine & Radiation Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Aruna Turaka
Aruna Turaka

Aruna Turaka
Physician, Radiation Oncology
Wendt Cancer center
Dubuque, Iowa 
Read Interview session with Aruna Turaka


Faculty Appointments 2011- Assistant professor, Fox Chase Cancer Center, 2009- 2011Clinical Instructor, Fox Chase Cancer Center 2008 - 2009Fellow, Radiation Oncology, Fox Chase Cancer Center2006 – 2007 Oncologist’s Associate, Department of Radiation Oncology, Metro hospitals & Cancer Institute, New Delhi, India. 2005 - 2006Research Officer, Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India. 2002 - 2005Senior Resident, Department of Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India , 1999 - 2002Resident in Radiation Oncology, All India Institute of Medical Sciences, New Delhi, India, 1996 – 1997 Internship, Government General Hospital, Guntur, Andhra Pradesh, India 1992 - 1996M.B.B.S, Guntur Medical College, Guntur, Andhra Pradesh, India

Research Interest

Aruna Turaka′s research interests are: Lung cancer involving the stereotactic body radiation therapy both for the primary and metastatic disease along with the role of different radiation therapy techniques for the resectable and unresectable NSCLC. Also, she is part of the clinical trials involving the use of targeted agents in the treatment of LANSCLC with concurrent chemoradiation therapy at Fox Chase Cancer Center. She has developed a database of the treatment of Head and neck malignancies with IMRT at FCCC during her fellowship, presented data at several national meetings and published in peer/non-peer reviewed journals.  she has also developed a database on ocular lymphoma and extra-nodal lymphoma and published/presented her work at different meetings. As a junior faculty at FCCC, she developed a database on the treatment outcomes for the Merkel Cell Carcinoma and presented abstracts in collaboration with the multispeciality teams at FCCC. Presently, she is developing a database on the SBRT outcomes for both the primary and metastatic lung cancer.  she has been given merit awards at national meetings for the H&N, Lymphoma presentations.


1. How many years have you been associated with the current research?
6 ½ years

2. What is the research topic you are working on now?
Lung and Lymphoma

3. What are attributes for a quality article?
Manuscripts supporting the research based on randomized studies and innovative techniques.

4. Do you have any research funding (NIH or other national funding) now?

5. When did you become an editor of OMICS Journal?
2 years

6. Where can the journal find the maximum scope in terms of niche?
Not sure of the question

7. What is your greatest career accomplishment?
NCI-LCWGC member (Lung working group committee member at NCI).

8. How does the published scientific content assist the potential researchers?
To design new trials/studies.

9. What is the purpose of serving as an editor?
Learning to be a leader, improve the research skills from broader variety of specialties, learning to be patient, calm and honest.

10. Do you have any patents?
Not sure what it means

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?
Yes, many

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?
Yes, after my board exams at the end this month.

13. How would you define your experience with OMICS Group?
so far excellent

14. Your opinion on conducting Editorial Board meetings at related Conferences?
I am looking forward to it, never attended so far.

15. Would you recommend OMICS to your friends or colleagues?
Yes, to all my colleagues, nationally and internationally.

16. How do you differentiate Journal of Nuclear Medicine & Radiation Therapy with other journals in the field?
We need to get the NIH publishers permission to make it pubmed release with impact factor given to the articles.